Literature DB >> 1636406

Results and evaluation of high volume intracapsular cataract surgery in Nepal.

A Hennig1, S P Shrestha, A Foster.   

Abstract

One thousand intracapsular cataract extractions were performed by two ophthalmologists over a 57-day period at Lahan Eye Hospital in Nepal. Ninety-nine per cent of eyes had a visual acuity of less than 3/60 at surgery. Ninety-eight per cent of eyes achieved a visual acuity of 3/60 or better with aphakic spherical correction at discharge, of which 69% had a visual acuity of 6/36 or better. In 314 eyes seen at 1-month follow-up, 88% achieved 6/18 or better with full aphakic correction. The surgical time averaged less than 10 min and the cost of disposables less than pounds 1 per operation.

Entities:  

Mesh:

Year:  1992        PMID: 1636406     DOI: 10.1111/j.1755-3768.1992.tb08587.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  Evaluation of high volume extracapsular cataract extraction with posterior chamber lens implantation in Sierra Leone, west Africa.

Authors:  N J Cook
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

2.  Long term clinical outcome of a randomised controlled trial of anterior chamber lenses after high volume intracapsular cataract surgery.

Authors:  A Hennig; G J Johnson; J R Evans; R Lagnado; A Poulson; D Pradhan; A Foster; R P Wormald
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

3.  Visual outcomes after cataract surgery and cataract surgical coverage in India.

Authors:  D Bachani; S K Gupta; G V Murthy; R Jose
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

4.  Monitoring and evaluating cataract intervention in India.

Authors:  H Limburg; R Kumar; D Bachani
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

5.  The South Asian Cataract Management Study. I. The first 662 cataract surgeries: a preliminary report.

Authors: 
Journal:  Br J Ophthalmol       Date:  1995-11       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.